David C. Dalgarno,Wei-Sheng Huang,William C. Shakespeare,Yihan Wang,Xiaotian Zhu
申请号：
US13464921
公开号：
US09834518B2
申请日:
2012.05.04
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The invention features compounds, pharmaceutical compositions and methods for treating patients who have an EGFR-driven cancer of formula I:wherein the variables are as defined herein.
